4//SEC Filing
Hansen Shannon Marie 4
Accession 0001438133-25-000207
CIK 0001438133other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:06 PM ET
Size
22.0 KB
Accession
0001438133-25-000207
Insider Transaction Report
Form 4
Hansen Shannon Marie
EVP & Chief Legal Officer
Transactions
- Tax Payment
Common Stock
2025-11-17$18.61/sh−393$7,314→ 21,474 total - Exercise/Conversion
Restricted Stock Unit
2025-11-17−530→ 531 total→ Common Stock (530 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-11-17−1,096→ 6,581 total→ Common Stock (1,096 underlying) - Exercise/Conversion
Common Stock
2025-11-17+530→ 20,039 total - Tax Payment
Common Stock
2025-11-17$18.61/sh−190$3,536→ 19,849 total - Exercise/Conversion
Common Stock
2025-11-17+1,096→ 21,867 total - Award
Common Stock
2025-11-17$15.59/sh+800$12,472→ 19,509 total - Exercise/Conversion
Common Stock
2025-11-17+1,437→ 21,286 total - Tax Payment
Common Stock
2025-11-17$18.61/sh−515$9,584→ 20,771 total - Exercise/Conversion
Restricted Stock Unit
2025-11-17−1,437→ 2,874 total→ Common Stock (1,437 underlying)
Holdings
- 1,935(indirect: By Trust)
Common Stock
Footnotes (11)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of May 16, 2025, through November 17, 2025. This transaction is also exempt under Rule 16b-3(c).
- [F10]Awarded on May 23, 2024 pursuant to the 2023 Plan.
- [F11]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
- [F2]Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
- [F3]The securities are held by the Shannon M. Hansen Trust dated July 8, 2003, of which Shannon M. Hansen is the Trustee.
- [F4]Awarded on February 15, 2022 pursuant to the Tandem Diabetes Care Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
- [F5]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
- [F6]RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 2/15/2023, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
- [F7]Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
- [F8]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F9]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Documents
Issuer
TANDEM DIABETES CARE INC
CIK 0001438133
Entity typeother
Related Parties
1- filerCIK 0001908267
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 4:06 PM ET
- Size
- 22.0 KB